The short version of MC4R agonist fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-09-12 and is reviewed periodically as new material appears.
The lyophilised solid is relatively stable when kept dry, protected from light and held at reduced temperature, commonly minus 20 degrees Celsius or lower for long-term storage. In solution the peptide is more vulnerable: tryptophan oxidation, hydrolysis of the lactam bridge and aggregation all become relevant over time, and the rate depends on pH, buffer composition and concentration. Repeated freeze-thaw cycles are generally avoided because they promote aggregation. Aqueous working solutions are typically prepared fresh or split into single-use aliquots to limit degradation before analysis.
Published studies differ in design, population and endpoint definition, so results are not always directly comparable across reports. Some trials used patient-reported measures of desire and distress, while others tracked physiological or behavioural outcomes. Questions that remain open include the durability of effects beyond short follow-up periods, the frequency of transient blood pressure elevation observed after administration, and whether a subtype-selective analogue could separate central effects from pigmentation-related activity. These points are usually framed as unresolved rather than settled in review literature.
PT-141 is the research code for bremelanotide, a cyclic heptapeptide derived from alpha-melanocyte-stimulating hormone. The molecule belongs to the melanocortin receptor agonist family and shows highest affinity for the MC4 receptor subtype, with weaker activity at MC1, MC3 and MC5. Its structure retains the core His-Phe-Arg-Trp sequence that defines melanocortin recognition, while cyclization and terminal modifications improve metabolic stability relative to the parent hormone. Early work classified the compound as a centrally acting agent rather than a peripherally acting vasodilator, which shaped subsequent development priorities.
Receptor activation in hypothalamic and limbic circuits is the mechanism most often cited for the observed effects on sexual desire. Signalling through MC4R couples to Gs proteins and raises intracellular cyclic AMP, which in turn modulates dopaminergic tone in reward-related pathways. Because the peptide reaches the central nervous system after subcutaneous administration, peripheral vascular changes are regarded as secondary rather than primary. The precise neural circuits that translate receptor occupancy into behavioural change remain incompletely mapped, and published accounts describe the pathway in general terms rather than as a fully resolved sequence.
| Property | Value | Notes |
|---|---|---|
| Solubility class | Freely soluble in water | Also soluble in DMSO and some alcohols |
| Typical storage temperature | -20 C or below | Desiccated, protected from light |
| Common analytical method | RP-HPLC with UV detection | Often paired with mass spectrometry |
| Typical reported purity | 95 percent or higher | Reference-grade material |
| Common synonyms | PT-141 | Also called bremelanotide acetate |
Clinical development proceeded through two routes of administration. An intranasal formulation advanced first, but variable absorption and tolerability problems led to a switch to subcutaneous injection. The United States Food and Drug Administration approved the subcutaneous product in 2019 for hypoactive sexual desire disorder in premenopausal women. Marketing rights subsequently changed hands, and commercial availability has fluctuated since approval. Use in men, in postmenopausal women, and in combination with other agents remains outside the approved label.
Outside the approved product, bremelanotide circulates as a research chemical sold by peptide vendors, often labelled PT-141. Such material is not manufactured under pharmaceutical quality standards, and independent testing has repeatedly found content that differs from the label. Analytical certificates supplied with a purchase are not strong evidence of purity because they are usually generated by the seller. Online discussion tends to blur the distinction between the approved drug and unregulated powder, which complicates interpretation of reported experiences.
PT-141 is the original development code for bremelanotide, a synthetic peptide first studied as a potential tanning and sexual-response agent in the 1990s. Researchers at a small American biotechnology firm designed it as a shortened analogue of melanotan II, which itself came from work on alpha-melanocyte-stimulating hormone. Early screening focused on pigmentation, but behavioural observations in animal models redirected attention toward sexual motivation. That shift made PT-141 one of the first melanocortin compounds investigated specifically for effects on desire rather than on skin colour.
PT-141 initiates cellular signaling by binding to specific subtypes within the melanocortin receptor family. These receptors belong to the G protein-coupled receptor superfamily, and activation raises intracellular cyclic adenosine monophosphate levels. This cascade ultimately influences neuronal circuits in the central nervous system that are associated with sexual desire and arousal. Research indicates the compound's action concentrates in hypothalamic regions rather than peripheral tissues, which helps explain some observed pharmacological features. The selectivity of receptor binding underlies its functional differences.
Compared with the related compound melanotan II, PT-141 shows markedly weaker activation of receptors tied to pigmentation. This difference stems from subtle structural variations that alter affinity distribution across receptor subtypes. Investigators propose that such selectivity produces a different side effect profile in specific applications. However, downstream consequences of prolonged receptor activation remain uncertain in the literature. Published studies do not fully agree on the duration of signaling pathway activity and the mechanisms of desensitization.
From a pharmacokinetic standpoint, the peptide is usually delivered by injection because oral bioavailability is very low; proteases in the digestive tract degrade it rapidly. After subcutaneous administration, plasma concentrations reach a peak within roughly one hour. Its elimination half-life is relatively short, with most reports placing it in the range of a few hours. Nasal formulations have also been examined, though absorption varies widely between individuals. Metabolism proceeds mainly through peptidase cleavage, and the resulting products are excreted by the kidneys.
Melanocortin receptors form a family of five G-protein-coupled receptors designated MC1 through MC5. Bremelanotide binds most strongly at MC4R and MC1R, with weaker activity reported at MC3R and MC5R. MC4R is expressed in hypothalamic nuclei that coordinate energy balance and aspects of sexual behaviour. The prevailing interpretation is that central MC4R activation, rather than peripheral vascular effects alone, drives the reported changes in desire. This account remains partly inferential, since direct receptor-level measurement in living humans is not practical.
After subcutaneous administration, plasma concentrations rise within roughly thirty minutes and the elimination half-life is short, on the order of two to three hours. Reported physiological responses include transient increases in blood pressure and nausea, which tended to diminish with repeated dosing in trial settings. Because the peptide clears quickly, effects are not expected to persist long after a dose. Absorption from non-injected routes is poorly characterised, and nasal delivery produced variable plasma levels in older work.
Clinical research typically uses randomised, double-blind, placebo-controlled designs. The most common primary endpoint is the desire domain score of the Female Sexual Function Index, sometimes paired with a distress measure. Secondary outcomes include arousal, satisfaction, and event-based counts of satisfying sexual episodes. Across trials, average improvements are modest and individual responses vary widely. Whether benefits persist beyond a few months, and whether they depend on baseline hormone status, remain open questions rather than settled findings.
Other options instead of death include conversion of an individual's consciousness into an AI, joining of a group mind (which can include biological and non-biological consciousnesses), or subliming (usually in association with a group mind). Concerning the lifespan of drones and Minds, given the durability of Culture technology and the options of mindstate backups, it is reasonable to assume that they live as long as they choose. Even Minds, with their utmost complexity, are known to be backed up (and reactivated if they for example die in a risky mission, see GSV Lasting Damage). It is noted that even Minds themselves do not necessarily live forever either, often choosing to eventually sublime or even killing themselves (as does the double-Mind GSV Lasting Damage due to its choices in the Culture-Idiran war).
Biomedical waste or hospital waste is any kind of waste containing infectious (or potentially infectious) materials generated during the treatment of humans or animals as well as during research involving biologics. It may also include waste associated with the generation of biomedical waste that visually appears to be of medical or laboratory origin (e.g. packaging, unused bandages, infusion kits etc.), as well research laboratory waste containing biomolecules or organisms that are mainly restricted from environmental release. As detailed below, discarded sharps are considered biomedical waste whether they are contaminated or not, due to the possibility of being contaminated with blood and their propensity to cause injury when not properly contained and disposed. Biomedical waste is a type of biowaste. Biomedical waste may be solid or liquid. Examples of infectious waste include discarded blood, sharps, unwanted microbiological cultures and stocks, identifiable body parts (including those as a result of amputation), other human or animal tissue, used bandages and dressings, discarded gloves, other medical supplies that may have been in contact with blood and body fluids, and laboratory waste that exhibits the characteristics described above. Waste sharps include potentially contaminated used (and unused discarded) needles, scalpels, lancets and other devices capable of penetrating skin. Biomedical waste is generated from biological and medical sources and activities, such as the diagnosis, prevention, or treatment of diseases.
=== Molecular electronics applications === Molecular 'switch' peptides can be made into nanoswitches when an electronic component is incorporated. Metal nanocrystals can be covalently linked to the peptides to make them electronically responsive; research is currently being conducted on how to develop electronically controlled molecules and molecular 'machines' using such molecular 'switches'. Peptide nanofibers can also be used as growth templates for a range of inorganic materials, such as silver, gold, platinum, cobalt, nickel, and various semiconducting materials. Electrons transferring aromatic moieties can also be attached to the side chains of peptides to form conducting nanostructures that can transfer electrons in a certain direction. Metal and semiconductor binding peptides have been used for the fabrication of nanowires. Peptides self-assemble into hollow nanotubes to act as casting molds; metal ions that migrate inside the tube undergo reduction to metallic form. The peptide 'mold' can then be enzymatically destroyed to produce a metal nanowire of about 20 nm diameter. This has been done making gold nanowires and this application is especially significant because nanowires at this scale cannot be made by lithography. Researchers have also successfully developed multi-layer nanocables with a silver core nanowire, a peptide insulation layer, and a gold outer coat. This is done by reducing AgNO3 inside nanotubes, and then bounding a layer of thiol-containing peptides with gold particles attached.
Sources: en.wikipedia.org
In national politics, there were numerous Calabrian politicians, often with a Risorgimento past behind them, who held important roles in the various Italian governments of that period: Giovanni Nicotera, participant of the Sapri Expedition and comrade of Carlo Pisacane, minister of the interior in the governments of Agostino Depretis and Antonio Di Rudinì, who headed a Left political formation called the Pentarchy because it included the major leaders of the historical Left (Rudinì, Francesco Crispi, Giuseppe Zanardelli, Alfredo Baccarini and Benedetto Cairoli), hostile to Depretis' transformist policies; Luigi Miceli, Mazzinian and Garibaldian, minister of Agriculture, Industry and Commerce in the third Cairoli government; Bernardino Grimaldi, minister of Finance in the first Crispi government and the first Giolitti government, culminated in the 1893 Banca Romana Scandal. During the 1880s, the economic conditions of the Mezzogiorno worsened, and its agricultural economy was severely damaged by the customs war that began between Italy and France in 1889: in fact, to protect its fragile industrial fabric, the Italian government raised import duties on foreign goods, to which France responded by shutting down imports of Italian agricultural goods, sending many southern farms into ruin. This, combined with the severe economic repression of those years, stimulated the phenomenon of emigration, especially to America, a fact that, while it decreased the demand for labor, left entire regions and countries depopulated and deprived these territories of their best energies.
List of fugitives from justice who disappeared List of kidnappings List of murder convictions without a body List of people who disappeared mysteriously (pre-1910) List of people who disappeared mysteriously (1910–1970) List of people who disappeared mysteriously (1970s) List of people who disappeared mysteriously (1980s) List of people who disappeared mysteriously (2000–present) Lists of solved missing person cases List of unsolved deaths
== Occurrence == The occurrence of unsaturated fats varies widely in nature. The saturated fatty acid components are almost exclusively stearic (C18) and palmitic acids (C16). Monounsaturated fats are almost exclusively oleic acid. Linolenic acid comprises most of the triunsaturated fatty acid component.
=== FTIR as detector in chromatography === The speed of FTIR allows spectra to be obtained from compounds as they are separated by a gas chromatograph. However this technique is little used compared to GC-MS (gas chromatography-mass spectrometry) which is more sensitive. The GC-IR method is particularly useful for identifying isomers, which by their nature have identical masses. Liquid chromatography fractions are more difficult because of the solvent present. One notable exception is to measure chain branching as a function of molecular size in polyethylene using gel permeation chromatography, which is possible using chlorinated solvents that have no absorption in the area in question.
Sources: en.wikipedia.org
Timothy Jostling & Donna Roberts (2001). "The Beef Hormone Dispute Between The United States and the EU". In Gerald C. Nelson (ed.). Genetically Modified Organisms in Agriculture: Economics and Politics. Academic Press. pp. 291–294. ISBN 0-12-515422-4. William A Kerr & Jill E Hobbs (February 2002). "The North American-European Union Dispute Over Beef Produced Using Growth Hormones: A Major Test for the New International Trade Regime". The World Economy. 25 (2): 283–296. doi:10.1111/1467-9701.00431. S2CID 154707486. SSRN 309524. Michael Balter (28 May 1999). "Scientific cross-claims fly in continuing beef war". Science. 284 (5419): 1453–1455. doi:10.1126/science.284.5419.1453. PMID 10383320. S2CID 5519384.
== History == Bromley is first recorded in an Anglo-Saxon charter of 862 as Bromleag and means 'woodland clearing where broom grows'. It shares this Old English etymology with Great Bromley in eastern Essex, but not with the Bromley in the East End of London. The history of Bromley is closely connected with the See of Rochester. In AD 862 Ethelbert, the King of Kent, granted land to form the Manor of Bromley. In 1185 Bromley Palace was built by Gilbert Glanvill, Bishop of Rochester. Pilgrims came to the town to visit St. Blaise's Well. The Palace was held by the Bishops until 1845, when Coles Child, a wealthy local merchant and philanthropist, purchased Bromley Palace and became lord of the manor. The town was an important coaching stop on the way to Hastings from London, and the Royal Bell Hotel (which has recently been reopened as of January 2026 and is just off Market Square) is referred to in Jane Austen's Pride and Prejudice. It was a quiet rural village until the arrival of the railway in 1858 in Shortlands, which led to rapid growth, and outlying suburban districts such as Bickley (which later overflowed into Bromley Common) were developed to accommodate those wishing to live so conveniently close to London. Bromley, also known as Bromley St Peter and St Paul, formed an ancient parish in the Bromley and Beckenham hundred and the Sutton-at-Hone lathe of Kent. In 1840 it became part of the expanded Metropolitan Police District. The parish adopted the Local Government Act 1858 and a local board was formed in 1867.
=== Articles === Rosen, DR; Siddique, T; Patterson, D; Figlewicz, DA; Sapp, P; Hentati, A; Donaldson, D; Goto, J; O'Regan, JP; Deng, HX; et al. (1993). "Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis". Nature. 364 (6435): 362. Bibcode:1993Natur.364..362R. doi:10.1038/364362c0. PMID 8332197. Gusella, JF; Wexler, NS; Conneally, PM; Naylor, SL; Anderson, MA; Tanzi, RE; Watkins, PC; Ottina, K; Wallace, MR; Sakaguchi, AY; Young, AB; Shoulson, I; Bonilla, E; Martin, JB (1983). "A polymorphic DNA marker genetically linked to Huntington's Disease". Nature. 306 (5940): 234–238. Bibcode:1983Natur.306..234G. doi:10.1038/306234a0. PMID 6316146. S2CID 4320711. Tanzi, RE; Gusella, JF; Watkins, PC; Bruns, GAP; St; George-Hyslop, PH; Van Keuren, ML; Patterson, D; Pagan, S; Kurnit, DM; Neve, RL. (1987). "The amyloid beta protein gene: cDNA cloning, mRNA distribution, and genetic linkage near the Alzheimer locus". Science. 235 (4791): 880–884. Bibcode:1987Sci...235..880T. doi:10.1126/science.2949367. PMID 2949367. Tanzi, RE; McClatchey, AI; Lamperti, ED; V-Komaroff, L; Gusella, JF; Neve, R (1988). "Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease". Nature. 331 (6156): 528–530. Bibcode:1988Natur.331..528T. doi:10.1038/331528a0. PMID 2893290. S2CID 4277294.
Sources: en.wikipedia.org
The peptide is polar and charged, and reversed-phase chromatography with acidic mobile phases resolves it well from related substances. Ultraviolet detection near 214 nm gives adequate sensitivity without derivatisation.
Aqueous solutions are subject to oxidation and hydrolysis, so concentration and pH drift can occur even under refrigeration. Solid, dry material held cold and desiccated degrades far more slowly.
Mass spectrometry separates the parent from analogues that differ by a single modification, such as an amide versus acid terminus. Retention time alone is less reliable because closely related peptides can co-elute.
The code designates bremelanotide, a cyclic heptapeptide melanocortin receptor agonist. It served as an internal research identifier before the compound entered formal clinical development. The code and the generic name refer to the same molecule.